Background The Khorana risk score (KRS) for prognosis of venous thromboembolism (VTE)
has been rarely explored in Hispanic populations. Objective To determine the value of the …

Introduction: Khorana score (KS) stratifies patients into low, intermediate, and high risk
groups for venous thromboembolism (VTE). We examined the generalizability of the KS to …

In this study we aimed to evaluate and compare the overall performance of the Khorana,
PROTECHT, and CONKO scores as predictive scores for the occurrence of venous …

Introduction Cancer associated venous thromboembolism (CAT) is one of the leading cause
of morbidity and mortality in the cancer population. Multiple scoring systems have been …

Abstract Background Although the Khorana venous thromboembolism (VTE) risk score
(KRS) is well recognized as a simple VTE risk assessment method in patients with cancer …

Background Oncology guidelines suggest using the Khorana score to select ambulatory
cancer patients receiving chemotherapy for primary venous thromboembolism (VTE) …

We aimed to evaluate the performance of the Khorana score in predicting venous
thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …

Abstract Background Risk assessment models (RAMs) are relevant approaches to identify
cancer outpatients at high risk of venous thromboembolism (VTE). Among the proposed …

Background: Guidelines suggest the use of the Khorana score to select patients with solid
cancer receiving chemotherapy for thromboprophylaxis to prevent venous thromboembolism …

BACKGROUND: Venous thromboembolism is a well-known complication of malignancy.
The Khorana Risk Score (KRS) utilizes the type of cancer, blood counts, and body mass …